CROSSJECT |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.97 EUR | -2.48% |
|
-6.64% | -60.36% |
| 05-03 | Crossject: praised for extended agreement on Zepizure | CF |
| 05-02 | Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Drug Delivery Systems
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 81.42M | - | - | ||||
| 217M | - |
- Stock Market
- Equities
- ALCJ Stock
- Charts Crossject
- Sector Chart
